Efficacy and Safety of Tralokinumab in US Adults with Moderate-to-Severe Atopic Dermatitis: A Post-hoc Analysis of ECZTRA3. (2023). SKIN The Journal of Cutaneous Medicine, 7(2), 686-695. https://doi.org/10.25251/skin.7.2.5